Recent Finacing
Recent Raise
Egle Therapeutics is a Paris-based clinical-stage biotech developing Treg-targeting immunotherapies for oncology and autoimmune diseases using single-cell target discovery, computationally designed IL-2 variants, engineered immunocytokines, and clinical-stage programs.
